The ω-carboxyl group of 7-ketocholesteryl-9-carboxynonanoate mediates the binding of oxLDL to CD36 receptor and enhances caveolin-1 expression in macrophages

Int J Biochem Cell Biol. 2017 Sep:90:121-135. doi: 10.1016/j.biocel.2017.07.022. Epub 2017 Aug 5.

Abstract

CD36 signal transduction modulates the uptake of oxidized low-density lipoprotein (oxLDL) and foam cell formation. We previously observed that 7-ketocholesteryl-9-carboxynonanoate (oxLig-1), the lipid moiety of oxLDL, activates the CD36-Src-JNK/ERK1/2 signalling pathway. In this study, we assessed the role of the ω-carboxyl group in the binding of oxLig-1 to CD36 and investigated whether the binding of the ω-carboxyl group to CD36 triggers CD36-mediated signalling, thereby resulting in the upregulation of caveolin-1 expression. Our results showed that oxLig-1 bound to CD36 and that the ω-carboxyl group was critical for this binding. Furthermore, immunoprecipitation and Western blot analyses showed that interaction between the ω-carboxyl group of oxLig-1 and CD36 triggered intracellular Src-JNK/ERK1/2 signal transduction. Moreover, the binding of the ω-carboxyl group to CD36 induced caveolin-1 expression and translocation to the membrane in macrophages. Additionally, inhibitors of Src, JNK and ERK and siRNA targeting CD36 and NF-κB significantly suppressed the enhanced caveolin-1 expression induced by oxLig-1. In conclusion, these observations suggest that oxLig-1 is a critical epitope of oxLDL that mediates the binding of oxLDL to CD36 and activates downstream Src-JNK/ERK1/2-NF-κB signal transduction, resulting in upregulation of caveolin-1 expression in macrophages.

Keywords: 7-Ketocholesteryl-9-carboxynonanoate; CD36; Caveolin-1; NF-κB; Oxidized low-density lipoprotein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD36 Antigens / chemistry
  • CD36 Antigens / metabolism*
  • Caveolin 1 / metabolism*
  • Cell Line
  • Cholesterol Esters / chemistry*
  • Cholesterol Esters / pharmacology*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Gene Expression Regulation / drug effects*
  • Humans
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Lipoproteins, LDL / chemistry
  • Lipoproteins, LDL / metabolism*
  • MAP Kinase Signaling System / drug effects
  • Macrophages / cytology
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Molecular Docking Simulation
  • NF-kappa B / metabolism
  • Protein Binding / drug effects
  • Protein Conformation
  • Protein Transport / drug effects
  • Proto-Oncogene Proteins c-fyn / metabolism
  • Structure-Activity Relationship

Substances

  • 7-ketocholesteryl-9-carboxynonanoate
  • CD36 Antigens
  • Caveolin 1
  • Cholesterol Esters
  • Lipoproteins, LDL
  • NF-kappa B
  • oxidized low density lipoprotein
  • Proto-Oncogene Proteins c-fyn
  • Extracellular Signal-Regulated MAP Kinases
  • JNK Mitogen-Activated Protein Kinases